Collection 專利 [0/39] 期刊論文 [110/113] 圖書 [1/1] 會議論文/會議摘要 [10/11] Siblings 余佳益 [17/17] 余冠儀 [41/41] 冷治湘 [61/106] 劉家齊 [45/52] 司徒惠康 [71/75] 吳綺容 [85/85] 周彥宏 [46/61] 宋旺洲 [33/37] 廖經倫 [32/37] 張仲明 [2/2] 張堯 [44/44] 曾凡真 [34/34] 曾才騰 [9/9] 李敏西 [61/69] 杜鴻運 [50/55] 楊采菱 [133/134] 潘建雄 [18/21] 羅秀容 [96/97] 胡勇誌 [23/24] 莊再成 [104/174] 蕭樑基 [158/161] 蘇益仁(2002-2015) [190/197] 許修誌(2005-2010) [1/1] 許素菁 [30/41] 謝鐸源(2006-2014) [20/27] 郭書辰 [140/142] 陳俊宏 [62/63] 陳信偉 [83/133] 陳宜君 [38/38] 陳逢叡 [41/41] 黃明熙 [52/69] 黃盈綺 [6/6] 齊嘉鈺 [46/46] McDonald LC(1998-2000) [12/12] 何曼德(1997-2002) [38/39] 其他 [179/180] 朱清良(2005-2007) [4/4] 梁蘭蘭(1998-2006) [6/6] 黃崑巖(1999-2004) [4/4] Community Statistics 近3年內發表的文件:16(9.76%) 含全文筆數:121(73.78%) 文件下載次數統計 下載大於0次:121(100.00%) 下載大於100次:117(96.69%) 檔案下載總次數:68705(1.21%) 最後更新時間: 2025-01-18 04:15 Top Upload Loading... Top Download Loading... Recent Submissions 基於核酸疫苗的方法 核酸-脂質奈米粒子及使用其之方法 含抗原和DNA之組成物及其用途 免疫原性胜肽及其用途 Compositions and methods for enhanc... 包含腫瘤相關抗原L6之B細胞抗原決定位之免疫原胜肽 人類乳突病毒之脂質抗原及用於人類乳突病毒相關疾病之免疫治療組合物 脂質化存活素（ＳＵＲＶＩＶＩＮ）及其用以預防及治療癌症之用途 登革病毒之細胞活體偵測及定量方法 脂質化多抗原表位疫苗

Jump to a point in the index: (Choose year) 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1985 1980 1975 1970 1960 1950 (Choose month) January February March April May June July August September October November December Or type in a year:

Ordering With Most Recent First Show Oldest First

Showing items 1-25 of 164. (7 Page(s) Totally) 1 2 3 4 5 6 7 > >> View [10|25|50] records per page

Date	Title	Relation
2024-09-10	Boosting DNA vaccine power by lipid nanoparticles surface engineered with amphiphilic bioresorbable copolymer	Molecular Therapy Nucleic Acids. 2024 Sep 10;35(3):Article number 102261.
2024-08-21	核酸-脂質奈米粒子及使用其之方法	TWI853485/2024-08-21
2024-05-21	含抗原和DNA之組成物及其用途	TWI843471/2024-05-21
2024-03-14	Lipid nanoparticle-encapsulated DNA vaccine robustly induce superior immune responses to the mRNA vaccine in Syrian hamsters	Molecular Therapy Methods and Clinical Development. 2024 Mar 14;32(1):Article number 101169.
2024-03	Inhibition of ADAM9 promotes the selective degradation of KRAS and sensitizes pancreatic cancers to chemotherapy	Nature Cancer. 2024 Mar;5(3):400-419.
2024	ADAM9 drives the immunosuppressive microenvironment by cholesterol biosynthesis-mediated activation of IL6-STAT3 signaling for lung tumor progression	American Journal of Cancer Research. 2024;14(4):1850-1865.
2023-12-08	增强免疫反应的组合物及方法	CN110691613/2023-12-08
2023-12	A broad-spectrum pneumococcal vaccine induces mucosal immunity and protects against lethal Streptococcus pneumoniae challenge	Emerging Microbes and Infections. 2023 Dec;12(2):Article number 2272656.
2023-09-11	基於核酸疫苗的方法	TWI815147/2023-09-11
2023-08-27	Co-delivery of a trimeric spike DNA and protein vaccine with aluminum hydroxide enhanced Th1-dominant humoral and cellular immunity against SARS-CoV-2	Journal of Medical Virology. 2023 Aug 27;95(8):Article number e29040.
2023-08-16	A TLR9 agonist synergistically enhances protective immunity induced by an Alum-adjuvanted H7N9 inactivated whole-virion vaccine	Emerging Microbes and Infections. 2023 Aug 16;12(2):Article number 2249130.
2023-08	Humoral and cellular immunity in three different types of COVID-19 vaccines against SARS-CoV-2 variants in a real-world data analysis	Journal of Microbiology, Immunology and Infection. 2023 Aug;56(4):705-717.
2023-06-02	Recombinant lipidated FLIPr effectively enhances mucosal and systemic immune responses for various vaccine types	npj Vaccines. 2023 Jun 02;8:Article number 82.
2023-05-29	TLR9 and STING agonists cooperatively boost the immune response to SARS-CoV-2 RBD vaccine through an increased germinal center B cell response and reshaped T helper responses	International Journal of Biological Sciences. 2023 May 29;19(9):2897-2913.
2023-05-01	ADAM9 drives immunosuppressive environment for lung tumor progression	Journal of Immunology. 2023 May 01;210(Suppl. 1):Abstract number 172.08.
2023-01-23	A flexible liposomal polymer complex as a platform of specific and regulable immune regulation for individual cancer immunotherapy	Journal of Experimental and Clinical Cancer Research. 2023 Jan 23;42:Article number 29.
2022-12-02	Omicron-specific mRNA vaccine induced cross-protective immunity against ancestral SARS-CoV-2 infection with low neutralizing antibodies	Journal of Medical Virology. 2022 Dec 2;95:Article number e28370.
2022-11-21	Formulation of SARS-CoV-2 spike protein with CpG oligodeoxynucleotides and squalene nanoparticles modulates immunological aspects following intranasal delivery	Pharmaceutics. 2022 Nov 21;14(11):Article number 2539.
2022-06-09	Induction of high affinity monoclonal antibodies against SARS-CoV-2 variant infection using a DNA prime-protein boost strategy	Journal of Biomedical Science. 2022 Jun 9;29:Article number 37.
2022-06-03	A DNA vaccine candidate delivered by an electroacupuncture machine provides protective immunity against SARS-CoV-2 infection	npj Vaccines. 2022 Jun 03;7:Article number 60.
2022-05-02	Furin and TMPRSS2 resistant spike induces robust humoral and cellular immunity against SARS-CoV-2 lethal infection	Frontiers in Immunology. 2022 May 2;13:Article number 872047.
2022-04-28	Low-dose SARS-CoV-2 S-trimer with an emulsion adjuvant induced th1-biased protective immunity	International Journal of Molecular Sciences. 2022 Apr 28;23(9):Article number 4902.
2022-04-22	Monoclonal antibody targeting the conserved region of the SARS-CoV-2 spike protein to overcome viral variants	JCI Insight. 2022 Apr 22;7(8):Article number e157597.
2022-03-08	Compositions and methods for enhancement of immune responses	US11266728/2022-03-08
2021-10-11	Intranasal vaccination with recombinant antigen-FLIPr fusion protein alone induces long-lasting systemic antibody responses and broad T cell responses	Frontiers in Immunology. 2021 Oct 11;12:Article number 751883.

Showing items 1-25 of 164. (7 Page(s) Totally) 1 2 3 4 5 6 7 > >> View [10|25|50] records per page